Although EGFR inhibitors have good efficacy for a variety of tumors, adverse reactions such as skin toxicity, interstitial lung disease, hepatotoxicity, ocular toxicity, hypomagnesemia, stomatitis, and diarrhea may occur during treatment (10). Here, EGFR is linked to toxicity.